NEW YORK, Feb. 8, 2017 /PRNewswire-USNewswire/
-- Bernstein Liebhard LLP is investigating whether the Board
of Directors of Teva Pharmaceuticals Industries, Ltd. ("Teva" or
the "Company") (NYSE: TEVA) breached their fiduciary duties to the
Company's shareholders.
On February 7, 2017, amid reports
of a bribery investigation, Teva announced that its Chief Executive
Officer Erez Vigodman will
resign. Teva shares fell approximately 6% on this adverse
news.
If you are interested in discussing your rights as a Teva
shareholder, and/or have information relating to the matter, please
contact Joseph R. Seidman, Jr. at (877) 779-1414
or seidman@bernlieb.com.
Bernstein Liebhard LLP has pursued hundreds of securities,
consumer and shareholder rights cases and recovered over
$3.5 billion for its
clients. The Firm has been named to the National Law Journal's
"Plaintiffs' Hot List" thirteen times.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414
www.bernlieb.com
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law
firm responsible for this advertisement is Bernstein Liebhard LLP,
10 East 40th Street, New York, New
York 10016, (212) 779-1414. The lawyer responsible for this
advertisement in the State of
Connecticut is Michael S. Bigin. Prior results do not
guarantee or predict a similar outcome with respect to any future
matter.
Contact Information
Joseph R. Seidman, Jr.
Bernstein Liebhard LLP
http://www.bernlieb.com
(212) 779-1414
seidman@bernlieb.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/bernstein-liebhard-llp-investigates-claims-on-behalf-of-shareholders-of-teva-pharmaceuticals-industries-ltd-300404607.html
SOURCE Bernstein Liebhard LLP